MedTrace Logo

Investigating the Impact of Ice Application on the Venous Puncture Pain in the Pediatric Population

NCT06089889 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2026-05-11

No results posted yet for this study

Summary

the goal of this RCT is: "To evaluate the effectiveness of a non-pharmacological method (ice application) in reducing venous puncture pain among children aged 5 to 7 years.".

An (RCT) will be conducted, involving 94 children, a non-probability convenience sampling will be used and children will randomly assign to two groups by lottery method. One group will receive ice application as an intervention, while other group will be control group, having no ice application.

Conditions

  • Venous Puncture Pain

Interventions

OTHER

ice application

* Group 1 will undergo the first intervention, which involves the application of ice. * Ice pack will be applied on the site of venipuncture prior to intravenous procedures for 3 minutes. * The procedure of venous puncture will be carried out in accordance with established standard operating procedures (SOPs). * pain will be assessed through Wong baker Faces Pain scale immediate after venous puncture procedure. after taking consent from parents/guardians, the pain response of children will be video taped for the purpose of objectively assessing the pain. and data will be kept confidential.

OTHER

control group

* Group 2 will be control group, which involves no ice application * The venipuncture procedure will be carried out according to established standard operating procedures (SOPs), pain will be assessed by Wong Baker Faces Pain Scale immediate after venous puncture procedure. After obtaining consent from parents/guardians, the pain responses of children will be videotaped for the purpose of objectively assessing pain, and the data will be kept confidential.

Sponsors & Collaborators

  • University of Health Sciences Lahore

    lead OTHER

Principal Investigators

  • sidra sultan, ms nursing · University of Health Sciences Lahore

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-12
Primary Completion
2024-11-30
Completion
2026-06-07

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06089889 on ClinicalTrials.gov